Rewalk Robotics

ReWalk Robotics will begin testing of its soft-suit exoskeleton for stroke victims, as part of a collaboration with Harvard University.

Revenue for Marlborough's ReWalk Robotics more than doubled in the second quarter on new orders for the company's walking-aid systems.

ReWalk Robotics, a manufacturer of systems to help those with spinal chord and similar injuries, has signed an agreement for exclusive distribution with a French health provider.

ReWalk Robotics Ltd., a manufacturer of robotic exoskeletons for those with spinal cord injuries, lost more than $6 million in its most recent quarter, despite a 21-percent increase in revenue.

ReWalk Robotics Ltd., a manufacturer of robotic exoskeletons for those with spinal cord injuries, has sold 28 of its systems to the U.S. Department of Veterans Affairs, it announced Thursday.

A securities fraud class action lawsuit has been filed against ReWalk Robotics in a Massachusetts federal court.

The Nasdaq Stock Market this month put on notice Marlborough medical device maker ReWalk Robotics, a warning that the company is in danger of being delisted from the exchange for failing to comply with the minimum $50-million market value, according to a filing by the company on Tuesday.

Governor Charlie Baker's upcoming visit to Israel carries on an important tradition of our state leadership—one that highlights the strong economic relationship between Massachusetts and Israel.

Despite an increase in revenue by 20 percent, net losses hit $7.9 million for the Marlborough medical device firm ReWalk Robotics in the third quarter.

ReWalk Robotics, the maker of the first publicly-available exoskeleton for paraplegics with U.S. headquarters in Marlborough, last week announced a public stock-and-warrants offering of $12 million.